Cervical cancer trials in France

In France 32 Also abroad 532

32 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Where
Bordeaux, Brest, Caen Cedex 5, Chambray-lès-Tours, Limoges, Paris, Pierre-Bénite, Strasbourg Cedex 2, Toulouse Cedex 9, Villejuif
Age
18 years and over
People
1,023 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07216703 · EU 2025-521514-26-00
Phase 1Taking people
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Where
Lyon, Saint-Herblain Cedex, Toulouse Cedex 9
Age
18 years and over
People
575 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00
Phase 1Taking people
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Where
Villejuif
Age
18 years and over
People
460 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00
Phase 2Taking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Bordeaux, Brest, Lille, Montpellier, Pierre-Bénite, Villejuif
Age
18 years and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
Phase 2Taking people
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Where
Angers, Dijon, Lyon, Marseille, Paris, Poitiers, Saint-Herblain Cedex
Age
18 years and over
People
750 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00
Phase 2Taking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Bordeaux, Dijon, Lille, Lyon, Marseille, Nantes, Toulouse, Vandœuvre-lès-Nancy, Villejuif
Age
18 years and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
Phase 1/2Taking people
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Where
Besancon Cedex, Bordeaux, Bordeaux Cedex, Dijon, Lyon, Montpellier Cedex 5, Paris, Rennes Cedex, Saint-Herblain Cedex, Toulouse Cedex 9, Villejuif
Age
18 years and over
People
680 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00
Phase 3Taking people
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Where
Angers, Bordeaux, Brest, Caen, Créteil, Dijon, Lille, Limoges, Lyon, Marseille, Montpellier, Nîmes, Paris, Pierre-Bénite, Reims, Rouen, Saint-Cloud, Saint-Herblain, Saint-Pierre, Strasbourg, Toulouse, Tours, Villejuif
Age
18 years and over
People
510 worldwide
Run by
Institut Claudius Regaud
See details and how to joinNCT05581121
Phase 1Taking people
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Where
Lyon, Paris, Saint-Herblain, Villejuif
Age
18 years and over
People
540 worldwide
Run by
SystImmune Inc.
See details and how to joinNCT05983432
No phaseTaking people
Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer
Where
Toulouse
Age
18 years and over
People
50
Run by
Institut Claudius Regaud
See details and how to joinNCT07821879
Phase 2Not yet taking people in France
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical Cancer
Where
Lyon, Paris
Age
18 years and over
People
63
Run by
ARCAGY/ GINECO GROUP
See details and how to joinNCT07763496 · EU 2026-527245-22-00
Phase 1/2Taking people
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Where
Villejuif
Age
18 years and over
People
366 worldwide
Run by
Marengo Therapeutics, Inc.
See details and how to joinNCT05592626 · EU 2023-505334-10-01
Phase 1/2Taking people
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Where
Bordeaux, Lyon, Marseille, Nice Cedex 2, Toulouse, Villejuif
Age
18 years and over
People
880 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00
Phase 1Taking people
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Where
Angers, Nice Cedex 2, Poitiers, Vandouvre Les Nancy, Villejuif
Age
18 years and over
People
1,006 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00
No phaseTaking people
Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer
Where
Nîmes
Age
18 years and over
People
180
Run by
Centre Hospitalier Universitaire de Nīmes
See details and how to joinNCT06147960
No phaseTaking people
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Where
Toulouse
Age
18 years and over
People
450
Run by
Institut Claudius Regaud
See details and how to joinNCT06967961
No phaseTaking people
Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy
Where
Pierre-Bénite, Strasbourg
Age
18 years and over
People
80
Run by
Centre Paul Strauss
See details and how to joinNCT07204535
Phase 2Taking people
A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
Where
Bordeaux, Caen Cedex 5, Clermont-Ferrand, Dijon, Marseille, Paris, Pierre-Bénite, Poitiers
Age
18 years and over
People
101 worldwide
Run by
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
See details and how to joinNCT05642780 · EU 2022-502654-14-00
No phaseTaking people
Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).
Where
Saint-Etienne
Age
30 years to 65 years
People
350
Run by
Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT06254846
No phaseTaking people
Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening
Where
Créteil
Age
25 years to 65 years
People
11,200
Run by
Centre Hospitalier Intercommunal Creteil
See details and how to joinNCT06527456
No phaseTaking people
Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme
Where
Carcassone
Age
30 years to 65 years
People
3,000
Run by
International Agency for Research on Cancer
See details and how to joinNCT05286034
No phaseTaking people
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
Where
Bordeaux, Lille, Lyon, Paris, Saint-Cloud, Vandœuvre-lès-Nancy
Age
18 years and over
People
1,050
Run by
Institut Curie
See details and how to joinNCT03017573
No phaseTaking people
Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC)
Where
Strasbourg
Age
18 years and over
People
50
Run by
Centre Paul Strauss
See details and how to joinNCT06083103
No phaseTaking people
A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
Where
Nîmes
Age
18 years and over
People
120
Run by
Centre Hospitalier Universitaire de Nīmes
See details and how to joinNCT07305727
No phaseTaking people
Deciphering Mechanisms Underlying Cancer Immunogenicity
Where
Toulouse
Age
18 years and over
People
1,100
Run by
Institut Claudius Regaud
See details and how to joinNCT03958240